510(k) · Cleared
ClearedIntelwave Heart Rate Variability System, Version 1.0
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Intelwave, LLC · DPS Electrocardiograph
Cleared on Oct 27, 2006 as substantially equivalent to K010955 (Boston Medical Technologies, Inc., 2001) and 3 other predicates after a 98-day review. Its family tree reaches back 3 generations to 1992. 1 later device descends from it.
- Decided
- Oct 27, 2006
- Review
- 98 days
- Class
- Class II
- Product code
- DPS
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 3 generations to K922171 (1992). 12 ancestors in all, the oldest K881905 (1988). 1 later device descends from it, 1 citing it directly.
- Root · 3 generations backK922171 Centra II Analysis SystemMarquette Electronics, Inc. · 1992
- 2 generations backK991786 Mars Unity Workstation with Heart Rate Variability (HRV) OptionGeneral Electric Medical Systems Information Techn · 1999
- 1 generation backK021230 HEROMedical Decision Networks · 2003
- This deviceK062068 Intelwave Heart Rate Variability System, Version 1.0Intelwave, LLC · 2006
- Descendant · cites it directly · 0 of its ownK142551 QANS (Quantitative Autonomic Nervous System) Monitoring SystemHhssystems, LLC · 2015
Most influential descendants
Showing 1 of 1 · See all- K142551QANS (Quantitative Autonomic Nervous System) Monitoring SystemHhssystems, LLC · 2015 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K922171 | Centra II Analysis System | Marquette Electronics, Inc. | 1992 | — |
| −2 | K991786 | Mars Unity Workstation with Heart Rate Variability (HRV) Option | General Electric Medical Systems Information Techn | 1999 | — |
| −1 | K021230 | HERO | Medical Decision Networks | 2003 | — |
| 0 (this device) | K062068 | Intelwave Heart Rate Variability System, Version 1.0 | Intelwave, LLC | 2006 | — |
| +1 | K142551 | QANS (Quantitative Autonomic Nervous System) Monitoring System | Hhssystems, LLC | 2015 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1988 | 2 | 0 |
| 1995 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2004 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DPS device
- #1 K212112 Cardiologs Holter Platformscore 18.6 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K010955 | BMT Anscore Health Management SystemSummary page 1…3. Predicate device. Intelwave 1.0 system is substantially equivalent to the following predicate devices: 1. Anscore TM Health Management System (510(k) K010955). 2. Holter PlusTM Ambulatory ECG Analysis System (510(k) K042463). 3. ANX 3.0 Respiratory and cardiac spectral frequen… | 2001 |
| * | K042463 | Holter PlusSummary page 1…alent to the following predicate devices: 1. Anscore TM Health Management System (510(k) K010955). 2. Holter PlusTM Ambulatory ECG Analysis System (510(k) K042463). 3. ANX 3.0 Respiratory and cardiac spectral frequency signal (510(k) K941252). 4. HeRO TM HRV analysis syste… | 2004 |
| * | K941252 | Respiratory and Cardiac Spectral Frequency Signal ProcessorSummary page 1…10(k) K010955). 2. Holter PlusTM Ambulatory ECG Analysis System (510(k) K042463). 3. ANX 3.0 Respiratory and cardiac spectral frequency signal (510(k) K941252). 4. HeRO TM HRV analysis system (510(k) K021230). CONFIDENTIAL 3/07/2006 PRE… | 1995 |
| * | K021230 | HEROSummary page 1…nalysis System (510(k) K042463). 3. ANX 3.0 Respiratory and cardiac spectral frequency signal (510(k) K941252). 4. HeRO TM HRV analysis system (510(k) K021230). CONFIDENTIAL 3/07/2006 PREMARKET NOTIFICATION 510(k)… | 2003 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K142551 | QANS (Quantitative Autonomic Nervous System) Monitoring System | 2015 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 14 years and passes through 4 companies; a new generation was cleared every 3.5 years on median.
- 1 of the 12 ancestors has a recall of any class.
- Of its descendants, K142551 (Hhssystems, LLC, 2015) has gone furthest, with 0 descendants of its own.
- 2 other devices also cite its predicate K010955.
How does its category compare?
All DPS devicesDPS Electrocardiograph: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DPS
6in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DPS
163in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DPS
3in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · DPS
55in 2025
MAUDE reports naming product code DPS, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 11 | 87 | 2 | 9 |
| 2008 | 13 | 31 | 0 | 17 |
| 2009 | 14 | 84 | 1 | 14 |
| 2010 | 11 | 104 | 2 | 21 |
| 2011 | 22 | 154 | 1 | 121 |
| 2012 | 12 | 117 | 0 | 56 |
| 2013 | 10 | 134 | 0 | 15 |
| 2014 | 11 | 253 | 0 | 15 |
| 2015 | 8 | 178 | 0 | 30 |
| 2016 | 11 | 229 | 0 | 12 |
| 2017 | 9 | 177 | 0 | 15 |
| 2018 | 14 | 221 | 0 | 19 |
| 2019 | 3 | 178 | 9 | 27 |
| 2020 | 6 | 224 | 2 | 59 |
| 2021 | 5 | 135 | 1 | 24 |
| 2022 | 6 | 244 | 1 | 59 |
| 2023 | 10 | 236 | 3 | 54 |
| 2024 | 8 | 260 | 4 (1) | 64 |
| 2025 | 6 | 163 | 3 | 55 |
| 2026 | 6 | 258 | 4 | — |
What is it indicated for?
The Intelwave 1.0 System is intended for use in Heart Rate Variability (HRV) measurements in response to paced respiration and controlled exercises.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K062068 · printed Nov 5, 2026
Cite this page
510(k) Report. “K062068: Intelwave Heart Rate Variability System, Version 1.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K062068
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026